SSRI: Clinical Trials

7 trials of SSRI, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 37Completed 7

Follow SSRI: new trials by email Literature Review of SSRI trials Research Report on SSRI

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressive Disorder
Vortioxetine 10-20 mg, Placebo, SSRI - Major Depressive Disorder
Phase 3CompletedH. Lundbeck A/S1512014-10-012017-05-24
A Study of LY2216684 in Participants With Major Depression Disorder
LY2216684, SSRI - Major Depressive Disorder
Phase 3CompletedEli Lilly and Company2882011-08-012018-10-25
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684, Placebo, SSRI - Major Depressive Disorder
Phase 3CompletedEli Lilly and Company12492011-05-012018-04-17
A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
LY2216684, Placebo, SSRI - Major Depressive Disorder (MDD)
Phase 3CompletedEli Lilly and Company14802011-03-012018-04-24
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
LY2216684, Placebo, SSRI - Major Depressive Disorder
Phase 3CompletedEli Lilly and Company10562011-03-012018-04-27
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
LY2216684, Placebo, SSRI - Major Depressive Disorder
Phase 3CompletedEli Lilly and Company14162010-11-012018-04-17
A Safety Study in Participants With Major Depressive Disorder
LY2216684 (edivoxetine), SSRI - Depressive Disorder, Major
Phase 3CompletedEli Lilly and Company6082010-10-012018-04-17

Conditions studied

Depressive Disorder, Major (7)  ·  Depression (1)

Sponsors

Eli Lilly and Company (6)  ·  H. Lundbeck A/S (1)

Countries

United States (5)  ·  Germany (3)  ·  Japan (3)  ·  Slovakia (3)  ·  Belgium (2)  ·  Croatia (2)  ·  Finland (2)  ·  Mexico (2)  ·  Puerto Rico (2)  ·  Russia (2)  ·  Spain (2)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Brazil (1)

Results publications

PMID 27035159, PMID 27685842, PMID 25894953

NIH funding

2014 (1)